Latest News about BioRestorative Therapies
Recent news which mentions BioRestorative Therapies
   BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
   
  
  
  February 13, 2024
  From Benzinga
 
   Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
   
  
  
  September 14, 2023
  From Benzinga
 
   As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
   
  
  
  August 29, 2023
  From Benzinga
 
   BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares
   
  August 01, 2023
  Tickers 
   BRTX
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It
   
  
  
  June 14, 2023
  From Benzinga
 From Benzinga
 
   BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion
   
  
  
  March 30, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
   
  
  
  February 10, 2023
  From Benzinga
 
   BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
   
  
  
  February 03, 2023
  From Benzinga
 
   2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
   
  
  
  January 25, 2023
  From Benzinga
 
   The NIH Has Given BioRestorative Therapies A Stamp Of Approval
   
  
  
  November 09, 2022
  From Benzinga
 
   See What's Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
   
  October 28, 2022
  Tickers 
   BRTX
  
  
  From Benzinga
 
   A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
   
  
  
  October 13, 2022
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
